Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 87% | 17% | 88% | 18% |
Total | 27 | 87% | 17% | 88% | 18% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 87% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 4 | 13% | 4 out of 31 |
Not Spiked | 103 | . | |
False Positives | 0 | 0% | 0 out of 102 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 73 | 86% | 13% | 86% | 12% |
Total | 73 | 86% | 13% | 86% | 12% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 73 | 99% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 75 | . | |
False Negatives | 1 | 1% | 1 out of 74 |
Not Spiked | 60 | . | |
False Positives | 0 | 0% | 0 out of 60 |
BQS OBSP Determination: |
17-ALPHA-ETHYNYLESTRADIOL |
METHOD: 4434 , TESTIDCODE: 64529GM005 |
Open Data Set |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 70 | 79% | 13% | 78% | 14% |
Total | 70 | 79% | 13% | 78% | 14% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 70 | 93% | Spiked |
Estimated Values | 4 | 5% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 76 | . | |
False Negatives | 5 | 7% | 5 out of 75 |
Not Spiked | 59 | . | |
False Positives | 0 | 0% | 0 out of 59 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 74 | 88% | 18% | 85% | 14% |
Total | 74 | 88% | 18% | 85% | 14% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 74 | 99% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 76 | . | |
False Negatives | 0 | 0% | 0 out of 75 |
Not Spiked | 59 | . | |
False Positives | 1 | 2% | 1 out of 59 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 91% | 24% | 91% | 19% |
Total | 63 | 91% | 24% | 91% | 19% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 93% | Spiked |
Estimated Values | 1 | 1% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 70 | . | |
False Negatives | 5 | 7% | 5 out of 68 |
Not Spiked | 54 | . | |
False Positives | 0 | 0% | 0 out of 54 |
Sample Statistics |
4,4BISPHENOL F |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | . | Spiked |
Estimated Values | 0 | . | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | . | Spiked |
Spiked | 0 | . | |
False Negatives | 0 | . | 0 out of 0 |
Not Spiked | 5 | . | |
False Positives | 0 | 0% | 0 out of 5 |
Sample Statistics |
4,4BISPHENOL S |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | . | Spiked |
Estimated Values | 0 | . | Spiked |
Deleted Values | 5 | 100% | Spiked + Not Spiked |
Spiked, Censored | 0 | . | Spiked |
Spiked | 0 | . | |
False Negatives | 0 | . | 0 out of 0 |
Not Spiked | 5 | . | |
False Positives | 0 | . | 0 out of 0 |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 69% | 21% | 70% | 19% |
Total | 35 | 69% | 21% | 70% | 19% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 35 |
Not Spiked | 99 | . | |
False Positives | 2 | 2% | 2 out of 98 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 107% | 10% | 106% | 4% |
>= Reporting Level | 51 | 77% | 21% | 73% | 23% |
Total | 56 | 79% | 22% | 77% | 23% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 95% | Spiked |
Estimated Values | 11 | 19% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 3 | 5% | Spiked |
Spiked | 61 | . | |
False Negatives | 0 | 0% | 0 out of 59 |
Not Spiked | 74 | . | |
False Positives | 0 | 0% | 0 out of 73 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 69 | 96% | 27% | 94% | 21% |
Total | 69 | 96% | 27% | 94% | 21% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 69 | 100% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 71 | . | |
False Negatives | 0 | 0% | 0 out of 69 |
Not Spiked | 53 | . | |
False Positives | 2 | 4% | 2 out of 53 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 60 | 80% | 25% | 79% | 17% |
Total | 60 | 80% | 25% | 79% | 17% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 100% | Spiked |
Estimated Values | 6 | 10% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 0 | 0% | 0 out of 60 |
Not Spiked | 75 | . | |
False Positives | 1 | 1% | 1 out of 73 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 231% | 76% | 226% | 84% |
>= Reporting Level | 33 | 65% | 24% | 65% | 9% |
Total | 38 | 87% | 66% | 66% | 12% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 38 | 97% | Spiked |
Estimated Values | 8 | 21% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 39 | . | |
False Negatives | 1 | 3% | 1 out of 39 |
Not Spiked | 96 | . | |
False Positives | 1 | 1% | 1 out of 95 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 58% | 18% | 52% | 5% |
>= Reporting Level | 53 | 76% | 20% | 73% | 12% |
Total | 58 | 75% | 21% | 72% | 14% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 100% | Spiked |
Estimated Values | 9 | 16% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 60 | . | |
False Negatives | 0 | 0% | 0 out of 58 |
Not Spiked | 75 | . | |
False Positives | 1 | 1% | 1 out of 75 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 79% | 38% | 73% | 39% |
Total | 39 | 79% | 38% | 73% | 39% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 98% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 1 | 3% | 1 out of 40 |
Not Spiked | 58 | . | |
False Positives | 7 | 12% | 7 out of 58 |
Plotted Points Statistics |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 71% | 18% | 64% | 1% |
>= Reporting Level | 58 | 64% | 19% | 64% | 18% |
Total | 63 | 64% | 19% | 64% | 18% |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 86% | Spiked |
Estimated Values | 63 | 86% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 75 | . | |
False Negatives | 9 | 12% | 9 out of 73 |
Not Spiked | 60 | . | |
False Positives | 0 | 0% | 0 out of 60 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 182% | 212% | 83% | 163% |
>= Reporting Level | 69 | 76% | 15% | 76% | 17% |
Total | 73 | 82% | 52% | 77% | 17% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 73 | 91% | Spiked |
Estimated Values | 9 | 11% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 81 | . | |
False Negatives | 6 | 8% | 6 out of 80 |
Not Spiked | 54 | . | |
False Positives | 3 | 6% | 3 out of 54 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 72 | 84% | 20% | 79% | 24% |
Total | 72 | 84% | 20% | 79% | 24% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 72 | 95% | Spiked |
Estimated Values | 6 | 8% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 76 | . | |
False Negatives | 2 | 3% | 2 out of 76 |
Not Spiked | 59 | . | |
False Positives | 0 | 0% | 0 out of 56 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 67 | 70% | 48% | 54% | 18% |
Total | 68 | 71% | 49% | 54% | 19% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 68 | 88% | Spiked |
Estimated Values | 4 | 5% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 77 | . | |
False Negatives | 9 | 12% | 9 out of 77 |
Not Spiked | 58 | . | |
False Positives | 1 | 2% | 1 out of 57 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 65 | 80% | 16% | 77% | 18% |
Total | 66 | 81% | 17% | 77% | 19% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 66 | 89% | Spiked |
Estimated Values | 6 | 8% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 75 | . | |
False Negatives | 6 | 8% | 6 out of 74 |
Not Spiked | 60 | . | |
False Positives | 0 | 0% | 0 out of 59 |
Plotted Points Statistics |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 41% | 17% | 48% | 10% |
>= Reporting Level | 63 | 49% | 23% | 46% | 15% |
Total | 68 | 49% | 23% | 46% | 14% |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 68 | 91% | Spiked |
Estimated Values | 68 | 91% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 5 | 7% | Spiked |
Spiked | 76 | . | |
False Negatives | 2 | 3% | 2 out of 75 |
Not Spiked | 59 | . | |
False Positives | 0 | 0% | 0 out of 59 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 45 | 80% | 14% | 80% | 11% |
Total | 45 | 80% | 14% | 80% | 11% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 98% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 2 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 46 | . | |
False Negatives | 1 | 2% | 1 out of 46 |
Not Spiked | 89 | . | |
False Positives | 0 | 0% | 0 out of 87 |
BQS OBSP Determination: |
TRANS-DIETHYLSTILBESTROL |
METHOD: 4434 , TESTIDCODE: 64536GM005 |
Open Data Set |